Medikly technology allows trial sponsors to discover physicians based on their work and characteristics that predispose them to research, or to recommend patients for a specific trial.
Ritesh Patel, global head of digital at inVentiv, told Outsourcing-Pharma.com that his company is “seeking to build communities with physicians across many therapeutic areas.”
The technology also enables trial sponsors to create online communities for investigators, develop medical education programs, as well as measure and apply metrics to understand how the healthcare providers respond to particular messages. Pharma companies can also use it to expand trial awareness, build trust with physicians, accelerate acquisition rates and improve relationships.
inVentiv selected Medikly due to their “platform around targeting doctors, understanding the interests they have, the conversations they are having online and the proprietary sentiment engine they have built,” Patel said. “They are unique and the only provider today of this engagement/intelligence service.”
Raymond Hill, EVP of Clinical for inVentiv, called the technology the future of clinical trial recruitment.
The partnership follows inVentiv’s investment from March in Mytrus, a virtual clinical trial company.
But Patel said neither of the partnerships seems to be about IT. “It’s less of an IT play and more about engagement platforms/intelligence gathering (Medikly) and efficiency gains (Medikly and Mytrus),” he added.
In other recent moves, inVentiv sold its sample management business in April and expanded its global presence with a partnership with Japanese CRO Bell Medical Solutions.